InTrack Investment Management’s Prologis PLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,880
Closed -$311K 103
2024
Q4
$311K Sell
2,880
-3,604
-56% -$414K 0.22% 93
2024
Q3
$819K Sell
6,484
-2,017
-24% -$250K 0.58% 55
2024
Q2
$955K Buy
8,501
+2,473
+41% +$274K 0.68% 44
2024
Q1
$785K Buy
6,028
+1,626
+37% +$212K 0.58% 58
2023
Q4
$587K Sell
4,402
-75
-2% -$8.51K 0.44% 72
2023
Q3
$502K Buy
4,477
+702
+19% +$85.9K 0.44% 78
2023
Q2
$463K Buy
3,775
+543
+17% +$66.8K 0.38% 88
2023
Q1
$401K Sell
3,232
-3,337
-51% -$410K 0.37% 86
2022
Q4
$741K Buy
6,569
+2,160
+49% +$239K 0.74% 47
2022
Q3
$448K Buy
4,409
+850
+24% +$105K 0.5% 68
2022
Q2
$419K Buy
3,559
+1,467
+70% +$203K 0.43% 74
2022
Q1
$338K Sell
2,092
-11,388
-84% -$1.74M 0.27% 97
2021
Q4
$2.27M Sell
13,480
-1,850
-12% -$276K 1.57% 13
2021
Q3
$2.22M Buy
15,330
+195
+1% +$25.3K 1.62% 13
2021
Q2
$1.85M Sell
15,135
-2,156
-12% -$252K 1.45% 18
2021
Q1
$1.83M Sell
17,291
-703
-4% -$71.6K 1.68% 17
2020
Q4
$1.79M Buy
+17,994
New +$1.82M 1.79% 16

Other funds holding PLD

InTrack Investment Management's PLD Position: Q1 2025 in Review

InTrack Investment Management sold out of Prologis (PLD) in Q1 2025, closing a stake of 2,880 shares — an estimated $311K sold.

InTrack Investment Management first reported a position in PLD in Q4 2020 and held it in 17 quarters. The position peaked at $2.27M in Q4 2021. 1,513 funds tracked by Wall St. Rank hold PLD as of Q1 2025.

  • InTrack Investment Management reported no remaining Prologis position as of Q1 2025 after selling out during the quarter.
  • InTrack Investment Management sold 2,880 Prologis shares in Q1 2025, an estimated $311K.
  • InTrack Investment Management first reported a position in Prologis in Q4 2020 and held it in 17 quarters.
  • InTrack Investment Management's Prologis position peaked at $2.27M in Q4 2021.
  • 1,513 funds tracked by Wall St. Rank held Prologis as of Q1 2025.

Based on InTrack Investment Management's 13F filing for Q1 2025, filed 15 Apr 2025.